eBsensor Glucose meter

(ISO13485:2003)

FDA 510K

Patent:

1. 2010.03.10 HUMAN PROTEIN PHOSPHATASE WITH EF-HANDS-1(PPEF-1)-RELATED GENE VARIANT ASSOCIATED WITH T-CELL LYMPHOBLASTIC LYMPHOMA.
   European Pat. NO 1903109
   United Kingdom Pat. No. 1903109
   Germany Pat. No. 602006012840.1-08
   Netherlands Pat. No. 1903109
   France Pat. No. 1903109
   Spain Pat. No. 1903109
   Italy Pat. No. 1903109
2. 2010.02.21 Received R.O.C Patent NO. D133384.
3. 2009.08.15 US patent NO 7,452,985.
4. 2009.05.06: Received R.O.C Patent NO. M1214002.
5. 2008.12.01 Received R.O.C Patent NO. M346004.
6. 2006.12.22 Received P.R.O.C Patent NO 876373.
7. 2006.9.11: Received R.O.C patent NO. M297470.

Safety Test:
　* Certificate Report No.:EME-95-0294
EMC Test:
　* Certificate Report No.:EME-95-0294(E)
Certification:
　* FDA 510K (No. K062555)
　* Visgeneer medical device factory has received ISO13485 : 2003
　　certification from TUV PS.
　* Visgeneer has received CE Mark (CE0123) for the eBsensor Blood Glucose
　　Monitoring System.
Clinical Report:
　* The clinical study of eBsensor entitled "Clinical evaluation of the eBsensor
　　 hand-held blood glucose monitoring system" was accepted for publication in
　　 Clin Chim Acta  377(1-2):170-3, 2007.

(ISO9001:2008)